Who is sponsoring NCT04023695?

NCT04023695 is sponsored by Vanderbilt University Medical Center.

What drugs are being tested in NCT04023695?

Interventions in NCT04023695: Corticosteroid with lidocaine with epinephrine, Corticosteroid with normal saline.

What condition does NCT04023695 study?

NCT04023695 studies Trigger Finger.

Is NCT04023695 still recruiting?

NCT04023695 is currently completed. Last updated 18 December 2019.

Are results published for NCT04023695?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-12-18 · How we verify

NCT04023695

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Trigger Finger Corticosteroid Injection With and Without Local Anesthetic

Completed Phase 4 Results posted Last updated 18 December 2019

What this trial tests

Phase 4 trial testing Corticosteroid with lidocaine with epinephrine in Trigger Finger in 110 participants. Completed in 30 August 2018.

Timeline

1 October 2017

Primary endpoint
30 August 2018

30 August 2018

Quick facts

Lead sponsor	Vanderbilt University Medical Center
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	110
Start date	1 October 2017
Primary completion	30 August 2018
Estimated completion	30 August 2018
Sites	1 location across United States

Drugs / interventions tested

Corticosteroid with lidocaine with epinephrine — full drug profile →
Corticosteroid with normal saline — full drug profile →

Conditions studied

Trigger Finger — all drugs for Trigger Finger →

Sponsor

Vanderbilt University Medical Center

Who can join

18 and older, any sex, with Trigger Finger. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Pain Outcome: Visual Analog Scale Primary · Assessed 1 minute after injection (in clinic)

Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever

Group	Value	95% CI
Corticosteroid With Lidocaine With Epinephrine	3.5	0 – 7
Corticosteroid With Normal Saline	2	0 – 8

Pain Outcome: Visual Analog Scale Primary · Assessed after 24 hours after injection (by phone)

Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever

Group	Value	95% CI
Corticosteroid With Lidocaine With Epinephrine	1.2	0 – 3
Corticosteroid With Normal Saline	1	0 – 6

Sponsor's own description

Steroid injection is the first line treatment for trigger finger. Steroid injection is sometimes mixed with a local anesthetic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Trigger Finger

Currently open trials in the same condition.

NCT07516652 — Prospective Randomized Trial Comparing Longitudinal vs. Transverse A1 Pulley Release · NA · recruiting
NCT07256522 — Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger · NA · recruiting
NCT06788860 — Efficacy of Ultrasound-Guided Needle Knife Release for Trigger Finger · NA · recruiting
NCT05837286 — Conservative Treatment of Trigger Finger · NA · recruiting
NCT05045157 — Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders · NA · recruiting

Other Vanderbilt University Medical Center trials

Trials by the same sponsor.

NCT07005037 — Swallowing Impairments in ICU Survivors and Community-Dwelling Adults · not yet recruiting
NCT07527273 — Cognitive Enhancement in Recurrent Depression (The COG-D-R Study) · NA · not yet recruiting
NCT07295288 — Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis · Phase 4 · not yet recruiting
NCT07431541 — Topical Carboxytherapy Paste Following Microneedling · Phase 1, PHASE2 · not yet recruiting
NCT07224711 — The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04023695 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vanderbilt University Medical Center
Last refreshed: 18 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04023695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing